399 related articles for article (PubMed ID: 10222386)
21. Bioavailability, disposition, and dose-response effects of soy isoflavones when consumed by healthy women at physiologically typical dietary intakes.
Setchell KD; Brown NM; Desai PB; Zimmer-Nechimias L; Wolfe B; Jakate AS; Creutzinger V; Heubi JE
J Nutr; 2003 Apr; 133(4):1027-35. PubMed ID: 12672914
[TBL] [Abstract][Full Text] [Related]
22. Sex and long-term soy diets affect the metabolism and excretion of soy isoflavones in humans.
Lu LJ; Anderson KE
Am J Clin Nutr; 1998 Dec; 68(6 Suppl):1500S-1504S. PubMed ID: 9848524
[TBL] [Abstract][Full Text] [Related]
23. Dietary isoflavone absorption, excretion, and metabolism in captive cheetahs (Acinonyx jubatus).
Whitehouse-Tedd KM; Cave NJ; Ugarte CE; Waldron LA; Prasain JK; Arabshahi A; Barnes S; Thomas DG
J Zoo Wildl Med; 2011 Dec; 42(4):658-70. PubMed ID: 22204061
[TBL] [Abstract][Full Text] [Related]
24. One-month exposure to soy isoflavones did not induce the ability to produce equol in postmenopausal women.
Védrine N; Mathey J; Morand C; Brandolini M; Davicco MJ; Guy L; Rémésy C; Coxam V; Manach C
Eur J Clin Nutr; 2006 Sep; 60(9):1039-45. PubMed ID: 16482068
[TBL] [Abstract][Full Text] [Related]
25. Metabolism and disposition of isoflavone conjugated metabolites in humans after ingestion of kinako.
Hosoda K; Furuta T; Ishii K
Drug Metab Dispos; 2011 Sep; 39(9):1762-7. PubMed ID: 21622628
[TBL] [Abstract][Full Text] [Related]
26. Influence of inulin on plasma isoflavone concentrations in healthy postmenopausal women.
Piazza C; Privitera MG; Melilli B; Incognito T; Marano MR; Leggio GM; Roxas MA; Drago F
Am J Clin Nutr; 2007 Sep; 86(3):775-80. PubMed ID: 17823445
[TBL] [Abstract][Full Text] [Related]
27. Isoflavonoid levels in spot urine are associated with frequency of dietary soy intake in a population-based sample of middle-aged and older Chinese in Singapore.
Seow A; Shi CY; Franke AA; Hankin JH; Lee HP; Yu MC
Cancer Epidemiol Biomarkers Prev; 1998 Feb; 7(2):135-40. PubMed ID: 9488588
[TBL] [Abstract][Full Text] [Related]
28. Metabolism of the soy isoflavones daidzein, genistein and glycitein in human subjects. Identification of new metabolites having an intact isoflavonoid skeleton.
Heinonen SM; Hoikkala A; Wähälä K; Adlercreutz H
J Steroid Biochem Mol Biol; 2003 Dec; 87(4-5):285-99. PubMed ID: 14698210
[TBL] [Abstract][Full Text] [Related]
29. Dietary fructooligosaccharides modify intestinal bioavailability of a single dose of genistein and daidzein and affect their urinary excretion and kinetics in blood of rats.
Uehara M; Ohta A; Sakai K; Suzuki K; Watanabe S; Adlercreutz H
J Nutr; 2001 Mar; 131(3):787-95. PubMed ID: 11238760
[TBL] [Abstract][Full Text] [Related]
30. Daidzein conjugates are more bioavailable than genistein conjugates in rats.
King RA
Am J Clin Nutr; 1998 Dec; 68(6 Suppl):1496S-1499S. PubMed ID: 9848523
[TBL] [Abstract][Full Text] [Related]
31. Daily intake and urinary excretion of genistein and daidzein by infants fed soy- or dairy-based infant formulas.
Irvine CH; Shand N; Fitzpatrick MG; Alexander SL
Am J Clin Nutr; 1998 Dec; 68(6 Suppl):1462S-1465S. PubMed ID: 9848517
[TBL] [Abstract][Full Text] [Related]
32. Estrogenic activity of glycitein, a soy isoflavone.
Song TT; Hendrich S; Murphy PA
J Agric Food Chem; 1999 Apr; 47(4):1607-10. PubMed ID: 10564025
[TBL] [Abstract][Full Text] [Related]
33. Soy isoflavone conjugation differs in fed and food-deprived rats.
Piskula MK
J Nutr; 2000 Jul; 130(7):1766-71. PubMed ID: 10867048
[TBL] [Abstract][Full Text] [Related]
34. Serum levels and metabolic clearance of the isoflavones genistein and daidzein in hemodialysis patients.
Fanti P; Sawaya BP; Custer LJ; Franke AA
J Am Soc Nephrol; 1999 Apr; 10(4):864-71. PubMed ID: 10203372
[TBL] [Abstract][Full Text] [Related]
35. Hydrolysis of isoflavone glycosides to aglycones by beta-glycosidase does not alter plasma and urine isoflavone pharmacokinetics in postmenopausal women.
Richelle M; Pridmore-Merten S; Bodenstab S; Enslen M; Offord EA
J Nutr; 2002 Sep; 132(9):2587-92. PubMed ID: 12221213
[TBL] [Abstract][Full Text] [Related]
36. Review of the factors affecting bioavailability of soy isoflavones in humans.
Nielsen IL; Williamson G
Nutr Cancer; 2007; 57(1):1-10. PubMed ID: 17516857
[TBL] [Abstract][Full Text] [Related]
37. Genistein, daidzein and glycitein inhibit growth and DNA synthesis of aortic smooth muscle cells from stroke-prone spontaneously hypertensive rats.
Pan W; Ikeda K; Takebe M; Yamori Y
J Nutr; 2001 Apr; 131(4):1154-8. PubMed ID: 11285318
[TBL] [Abstract][Full Text] [Related]
38. Effect of a soymilk supplement containing isoflavones on urinary F2 isoprostane levels in premenopausal women.
Nhan S; Anderson KE; Nagamani M; Grady JJ; Lu LJ
Nutr Cancer; 2005; 53(1):73-81. PubMed ID: 16351509
[TBL] [Abstract][Full Text] [Related]
39. Novel effects of phytoestrogenic soy isoflavones on serum calcium and chloride in premenopausal women: A 2-year double-blind, randomized, placebo-controlled study.
Lu LW; Chen NW; Nayeem F; Ramanujam VS; Kuo YF; Brunder DG; Nagamani M; Anderson KE
Clin Nutr; 2018 Dec; 37(6 Pt A):1862-1870. PubMed ID: 29183775
[TBL] [Abstract][Full Text] [Related]
40. LC/UV/ESI-MS analysis of isoflavones in Edamame and Tofu soybeans.
Wu Q; Wang M; Sciarappa WJ; Simon JE
J Agric Food Chem; 2004 May; 52(10):2763-9. PubMed ID: 15137811
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
